GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

William Preston

doi:10.1056/NEJMc2311840

GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2303
Number of pages	1
Journal	The New England journal of medicine
Volume	389
Issue number	24
DOIs	https://doi.org/10.1056/NEJMc2311840
State	Published - Dec 14 2023

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMc2311840

Cite this

@article{8ab051552ee34bf79cde74c328e3f762,

title = "GLP-1 Receptor Agonist Orforglipron for Adults with Obesity",

author = "William Preston",

year = "2023",

month = dec,

day = "14",

doi = "10.1056/NEJMc2311840",

language = "English (US)",

volume = "389",

pages = "2303",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "24",

}

TY - JOUR

T1 - GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

AU - Preston, William

PY - 2023/12/14

Y1 - 2023/12/14

UR - http://www.scopus.com/inward/record.url?scp=85179648437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85179648437&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2311840

DO - 10.1056/NEJMc2311840

M3 - Letter

C2 - 38091541

AN - SCOPUS:85179648437

SN - 0028-4793

VL - 389

SP - 2303

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 24

ER -

GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this